Results 131 to 140 of about 216,693 (188)

Recurrence of C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis After Kidney Transplantation: Challenges and Opportunities. [PDF]

Kidney Int Rep
Ruiz-Cabello JE, Trujillo H, Cavero T, Andrés A, Praga M, Caravaca-Fontán F.   +5 more
europepmc   +1 more source

<i>Moss-derived</i> recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathy. [PDF]

Front Immunol
Imanifard Z, Penati F, Padoa S, Dabrowska-Schlepp P, Bresin E, Peracchi T, Benigni A, Remuzzi G, Noris M, Donadelli R.   +9 more
europepmc   +1 more source

Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis. [PDF]

Kidney Int Rep
Kavanagh D, Ariceta G, Vivarelli M, Schaefer F, Caravaca-Fontán F, Frémeaux-Bacchi V, Fakhouri F, Licht C, Pickering MC.   +8 more
europepmc   +1 more source

When a NeF Is Not Enough: Improving Assays in C3 Glomerulopathy. [PDF]

J Am Soc Nephrol
Canetta P.
europepmc   +1 more source

Real-World Patient Characteristics, Burden, and Quality of Life in C3 Glomerulopathy and Primary Immune Complex Membranoproliferative GN. [PDF]

Kidney360
Caravaca-Fontan F, Norouzi S, Huang M, Gordon K, Clayton S, Lowe M, Fitzmaurice K, Middleton-Dalby C, Quintana-Gallardo L, Rich C.   +9 more
europepmc   +1 more source

C3 glomerulopathy post kidney transplantation: A single center experience. [PDF]

World J Transplant
Zuckerman J, Pham PT, Parakkal M, Velazquez AF, Sarkar M, Pablos MA, Bunnapradist S, Lum EL.   +7 more
europepmc   +1 more source

The Role of von Willebrand Factor in the Pathogenesis of C3 Glomerulopathy. [PDF]

Kidney Int Rep
Hua Z, Chen Y, Han S, Yu X, Tan Y, Yu F, Chen M, Zhao M.   +7 more
europepmc   +1 more source

Why Is C5a Inflammatory Complement Inhibition Not Enough to Improve C3 Glomerulopathy? [PDF]

J Am Soc Nephrol
Zipfel PF, Skerka C.
europepmc   +1 more source

Natural History and Clinical Associations with Long-Term Outcomes in Primary C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative GN. [PDF]

Clin J Am Soc Nephrol
Nanchen G, Marasà M, Breno M, Martinatto C, Rigoldi M, Noris M, Bresin E, Gamba S, Gamba S, Bottanelli L, Bottanelli L, Imanifard Z, Piras R, Donadelli R, Trillini M, Emma F, Vivarelli M, Antonucci L, Carrara C, Ruggenenti P, La Manna G, Comai G, Vidal E, Silecchia V, Pasini A, Ranghino A, Cingolani A, Donati G, Giovanella S, Biancone L, Valenza L, Verrina E, Angeletti A, Brunori G, Sottini L, Giordano M, Torres DD, Alberici F, Mescia F, Maggiore U, Gentile M, Benigni A, Remuzzi G, Daina E, Italian Registry of MPGN.   +44 more
europepmc   +1 more source

IdeZ protease does not prevent convertase stabilization by C3 nephritic factors in C3 glomerulopathy. [PDF]

Nephrol Dial Transplant
Stevens KH, Baas LM, van de Kar NCAJ, van den Heuvel LPWJ, Michels MAHM.   +4 more
europepmc   +1 more source